Vincent H. Tam

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 931 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Roger L. Nation, Jian Li, Otto Cars et al. · The Lancet Infectious Diseases · 2014 · 343 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +15

Pharmacodynamics of cefepime in patients with Gram-negative infections

Vincent H. Tam · Journal of Antimicrobial Chemotherapy · 2002 · 265 citations

Medicine, Pharmacokinetics, Pharmacology +16

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

Nelson L. ‘Shasha’ Jumbe, Arnold Louie, Robert Leary et al. · Journal of Clinical Investigation · 2003 · 239 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

Nelson L. ‘Shasha’ Jumbe, Arnold Louie, Robert Leary et al. · Journal of Clinical Investigation · 2003 · 233 citations · Full text

Life Sciences, Microbiology, Pharmacology +17